Hyundai Bioscience Co., Ltd. (048410.KQ)
KRW 10770.0
(0.19%)
KRW 10770.0
(0.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.48 Billion | 7.85 Billion | 9.24 Billion | 12.51 Billion | 30.08 Billion | 31.23 Billion |
| Cost of Revenue | 4.44 Billion | 5.9 Billion | 7.71 Billion | 9 Billion | 18.63 Billion | 17.51 Billion |
| Gross Profit | 5.04 Billion | 1.94 Billion | 1.52 Billion | 3.5 Billion | 11.45 Billion | 13.71 Billion |
| Operating Expenses | 14.82 Billion | 28.25 Billion | 10.81 Billion | 7.93 Billion | 9.03 Billion | 12.24 Billion |
| Selling, General and Administrative Expenses | 7.88 Billion | 11.77 Billion | 6.35 Billion | 6.22 Billion | 7.01 Billion | 9.91 Billion |
| Research and Development Expenses | 6.4 Billion | 16.45 Billion | 4.39 Billion | 1.67 Billion | 1.29 Billion | 1.7 Billion |
| Other Expenses | - | -27.36 Million | -61.28 Million | -40.98 Million | -734.01 Million | -630.45 Million |
| Cost and Expenses | 19.26 Billion | 34.16 Billion | 18.53 Billion | 16.94 Billion | 27.66 Billion | 29.76 Billion |
| Operating Income | -9.78 Billion | -26.31 Billion | -9.28 Billion | -4.42 Billion | 2.41 Billion | 1.46 Billion |
| Interest Expense | 314.57 Million | 448.65 Million | 3 Billion | 1.13 Billion | 774.01 Million | 1.04 Billion |
| Income Tax Expense | 1.04 Million | -805.47 Million | 243.49 Million | 326.46 Million | 78.94 Million | 150.15 Million |
| Earnings before Tax | -14.49 Billion | -17.08 Billion | -19.9 Billion | -9.47 Billion | 1.91 Billion | 2.76 Billion |
| Net Income | -14.49 Billion | -15.8 Billion | -20.05 Billion | -8.25 Billion | 767.21 Million | 2.61 Billion |
| Earnings Per Share Basic | -365.00 | -401.53 | -543.16 | -229.99 | 22.15 | 77.64 |
| Earnings Per Share Diluted | -364.53 | -401.53 | -543.16 | -229.99 | 22.15 | 77.64 |
| Weighted Average Shares Outstanding | 39.72 Million | 39.36 Million | 36.91 Million | 35.91 Million | 34.64 Million | 33.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.77 Million | 39.36 Million | 36.91 Million | 35.91 Million | 34.64 Million | 33.71 Million |
| Gross Margin | 0.53 | 0.25 | 0.17 | 0.28 | 0.38 | 0.44 |
| EBIT Margin | -1.34 | -3.12 | -0.71 | -0.05 | 0.21 | 0.11 |
| Profit Margin | -1.53 | -2.01 | -2.17 | -0.66 | 0.03 | 0.08 |
| EBITDA | -12.74 Billion | -14.85 Billion | -14.19 Billion | -4.56 Billion | 6.23 Billion | 5.64 Billion |
| Earnings Before Tax Margin | -1.03 | -3.35 | -1.01 | -0.35 | 0.08 | 0.05 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.09 Billion | 5.04 Billion | 9.48 Billion | 1.13 Billion | 1.96 Billion | 3.22 Billion |
| Cost of Revenue | 1.09 Billion | 2.25 Billion | 5.55 Billion | 922.37 Million | 1.19 Billion | 1.72 Billion |
| Gross Profit | -5.05 Million | 2.79 Billion | 3.92 Billion | 211.32 Million | 769.59 Million | 1.49 Billion |
| Operating Expenses | 3.86 Billion | 1.57 Billion | 13.72 Billion | 3.72 Billion | 2.78 Billion | 3.47 Billion |
| Selling, General and Administrative Expenses | 2.59 Billion | 1.89 Billion | - | 2.53 Billion | 1.58 Billion | 2.1 Billion |
| Research and Development Expenses | 1.24 Billion | -319.86 Million | - | 1.18 Billion | 1.18 Billion | 1.35 Billion |
| Other Expenses | -17.63 Million | -6.58 Million | -42.25 Million | -7 Million | -17.24 Million | -11.98 Million |
| Cost and Expenses | 4.96 Billion | 3.82 Billion | 19.28 Billion | 4.64 Billion | 3.97 Billion | 5.19 Billion |
| Operating Income | -3.86 Billion | 1.22 Billion | -9.8 Billion | -3.51 Billion | -2.01 Billion | -1.97 Billion |
| Interest Expense | 394.18 Million | 78.27 Million | 314.57 Million | 60.55 Million | 100.26 Million | 77.42 Million |
| Income Tax Expense | 132.79 Million | 4.00 | 1.04 Million | 4208.00 | 4328.00 | 1.03 Million |
| Earnings before Tax | -4.41 Billion | 1.18 Billion | -14.49 Billion | -8.08 Billion | -1.97 Billion | -2.33 Billion |
| Net Income | 2.3 Billion | 1.18 Billion | -14.49 Billion | -8.08 Billion | -1.97 Billion | -2.33 Billion |
| Earnings Per Share Basic | 57.94 | 29.77 | - | -203.13 | -49.72 | -58.73 |
| Earnings Per Share Diluted | 57.94 | 29.77 | - | -203.13 | -49.72 | -58.73 |
| Weighted Average Shares Outstanding | 39.81 Million | 39.81 Million | 39.77 Million | 39.8 Million | 39.8 Million | 39.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 39.81 Million | 39.81 Million | 39.77 Million | 39.8 Million | 39.8 Million | 39.79 Million |
| Gross Margin | -0.00 | 0.55 | 0.41 | 0.19 | 0.39 | 0.46 |
| EBIT Margin | -3.28 | 0.27 | - | -2.89 | -0.85 | -0.48 |
| Profit Margin | 2.11 | 0.23 | -1.53 | -7.13 | -1.01 | -0.73 |
| EBITDA | -3.58 Billion | 1.36 Billion | - | -3.28 Billion | -1.66 Billion | -1.55 Billion |
| Earnings Before Tax Margin | -3.54 | 0.24 | -1.03 | -3.10 | -1.03 | -0.61 |
NGL-PC
UDAICEMENT
KMNCF
195870
0989
005389